Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Blood Typing01:10

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utilization of the All of Us Research Program in a study of genetics in Yao syndrome.

The Journal of allergy and clinical immunology·2025
Same author

Genetically Transitional Disease and the Road to Personalized Medicine.

Genes·2025
Same author

Comprehensive clinical phenotype, genotype and therapy in Yao syndrome.

Frontiers in immunology·2024
Same author

Genetically transitional disease: conceptual understanding and applicability to rheumatic disease.

Nature reviews. Rheumatology·2024
Same author

Genetic variations in NLRP3 and NLRP12 genes in adult-onset patients with autoinflammatory diseases: a comparative study.

Frontiers in immunology·2024
Same author

Cardiac Amyloidosis.

Annals of internal medicine·2023

Related Experiment Video

Updated: May 18, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Rheumatoid factor, complement, and mixed cryoglobulinemia.

Peter D Gorevic1

  • 1Mount Sinai School of Medicine, Division of Rheumatalogy, Annenberg Building, Room 21-056, One Gustave L. Levy Place, New York, NY, USA. peter.gorevic@mountsinai.org

Clinical & Developmental Immunology
|September 8, 2012
PubMed
Summary

Low serum complement component 4 (C4) in mixed cryoglobulinemia (MC) is linked to complement activation. This may involve classical, alternative, or lectin pathways, especially with hepatitis C virus (HCV) infection.

More Related Videos

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
10:16

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

Published on: September 15, 2016

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry
07:20

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry

Published on: May 19, 2020

Related Experiment Videos

Last Updated: May 18, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
10:16

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

Published on: September 15, 2016

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry
07:20

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry

Published on: May 19, 2020

Area of Science:

  • Immunology
  • Complement System Biology

Background:

  • Mixed cryoglobulinemia (MC) is associated with low serum levels of complement component 4 (C4).
  • Complement activation, particularly via the classical pathway, is implicated in the pathogenesis of MC.
  • Hepatitis C virus (HCV) infection can contribute to immune stimulation and complement pathway activation in MC.

Purpose of the Study:

  • To investigate the mechanisms of complement activation in mixed cryoglobulinemia.
  • To explore the role of various complement pathways (classical, alternative, lectin) in MC.
  • To understand the contribution of hepatitis C virus (HCV) to complement dysregulation in MC.

Main Methods:

  • Analysis of complement component 4 (C4) serum levels.
  • Investigation of complement activation pathways, including classical, alternative, and lectin pathways.
  • Assessment of immune complex (IC) formation, clearance, and localization.

Main Results:

  • Low C4 levels in MC suggest in vivo or ex vivo complement activation.
  • Potential activators include monoclonal IgM rheumatoid factor (RF), IgG antibodies, and cryocomplexes.
  • HCV infection may drive alternative and lectin pathway activation.
  • Immune complexes (ICs) localize to microcirculations, with defective clearance contributing to persistence.
  • Complement activation generates phlogistic fragments and the membrane attack complex (C5b-9).

Conclusions:

  • Complement activation is a key feature of mixed cryoglobulinemia (MC), contributing to its pathology.
  • Understanding complement activation pathways in MC, especially in HCV infection, is crucial.
  • Further research should focus on the effector mechanisms and viral contributions to complement activation in MC.